Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
5.06M
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
79.4K
-
Shares change
-
+58.8K
-
Total reported value, excl. options
-
$152K
-
Value change
-
+$100K
-
Number of buys
-
4
-
Number of sells
-
-3
-
Price
-
$1.91
Significant Holders of Sunshine Biopharma Inc. - Common Stock, $0.001 par value (SBFM) as of Q1 2025
13 filings reported holding SBFM - Sunshine Biopharma Inc. - Common Stock, $0.001 par value as of Q1 2025.
Sunshine Biopharma Inc. - Common Stock, $0.001 par value (SBFM) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 79.4K shares
of 5.06M outstanding shares and own 1.57% of the company stock.
Largest 10 shareholders include Altium Capital Management LLC (50.5K shares), UBS Group AG (19.9K shares), SBI Securities Co., Ltd. (5.22K shares), MORGAN STANLEY (3.83K shares), NATIONAL BANK OF CANADA /FI/ (10 shares), BANK OF AMERICA CORP /DE/ (5 shares), OSAIC HOLDINGS, INC. (2 shares), Farther Finance Advisors, LLC (1 shares), TD Waterhouse Canada Inc. (1 shares), and Rise Advisors, LLC (1 shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.